Crosscope Dx is a workflow integrated vendor-agnostic digital pathology platform that offers end-to-end digital pathology solutions with advanced workflow features
Global event to kick off as the post-covid era begins in earnest, with theme "beyond the pandemic, into a next wave"
Drones will be used in the Gurugram and Mumbai region to transport pathology samples
Through this partnership, Premas will connect with genomics labs to provide automated NGS solutions
Co–Founder Sam Santhosh steps down as Chairman and Group CEO; will remain on Board of Directors. Co–founder Mahesh Pratapneni appointed Group CEO. Dr. Felix Olale appointed Chairman of the Board
Building the future of food in the birthplace of cell-cultured milk
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
_256_384.jpg)
The Indian companies that have been granted licences are Cipla, Sun Pharma, Laurus Labs, Divis Labs, Glenmark, Cadila, Torrent, Emcure, McLeods, SMS Pharmaceuticals, Strides, Biocon, Aurobindo Pharma, Hetero, Granules, Amneal, MSN, Arene Life Sciences and Viatris
Empowers the lab to do more in less time within the existing floor plan by integrating clinical chemistry and immunoassay testing onto a single platform
He was earlier associated with leading industry players like Hindustan Unilever, TATA Communications, Dr. Lal Path Labs, Oncquest and Metropolis Healthcare
Subscribe To Our Newsletter & Stay Updated
